By continuing to visit this website, you agree to cookies and other methods, means and tools of Internet statistics and settings used on the website to improve its usability. View more
GEN Farma Rus LLC company is a dynamically developing company in pharmaceutical market. We are creating future portfolio of products according to
✓⠀high efficiency for patients
✓ high efficiency for patients
The basis of our development strategy is a number of long-time exclusive license and supply agreements and mutually profitable business relationship with international pharmaceutical manufacturers.
To unite the world's best pharmaceutical manufacturers and supply modern and high-quality products.
Effective and ethical communication with the end-consumer.
The most important value of a person is a sense of security and reliability.
With the start of commercial activities and the introduction of medicines included in the company's portfolio to the market, we will place a feedback form for possibility of reporting adverse product reactions.
This is equally important for a pharmaceutical company. Each partner of GEN Farma Rus LLC is a manufacturer of medicines of high and stable quality. This is confirmed by numerous audits for compliance with the EAEU GMP rules.
GEN Farma Rus LLC has implemented the Quality Management System to ensure the quality of medicines on the EAEU territory.
The Quality Policy is part of the Quality Guideline of GEN Farma Rus LLC and contains the strategy and principles aimed at fulfilling the mission of the company.
GEN Farma Rus LLC exclusively offers its international partners manufacturing medical products support in the following areas:
Clinical trials & registration in the EAEU and Russia at the expense of GEN Farma Rus LLC

Integrated marketing communication and promotion in the professional environment and among KOL of the product group

Cooperation with key healthcare centers and pharmaceutical social networks
GEN Farma Rus LLC
Ostrovnoy pass. 12, bld. 1, Moscow, 121552, Russia
+ 7 (495) 902-72-79 /
Pharmaceutical license №Л042-00110-77/00670187 (date of licensing: 15.08.2023)